Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05843877 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pancreatic Head Resection or Total Pancreatectomy With Islet Autotransplantation in Patients With Periampullary Cancer and High Risk Profile for the Development of Postoperative Pancreatic Fistula

Study acronym: XandTX
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv7
  2. Start date changed from estimate of Jan 2025 to Jan 28, 2025v6
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Oct 2024 to Jan 2025
    • Site details revised
    v5
  4. Start date: Jun 2024 to Oct 2024v4
  5. Start date: Dec 2023 to Jun 2024v3
  6. Start date: Jun 2023 to Dec 2023
    • Primary and study completion dates: Jul 2027 to Jan 2028
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The primary objective of this clinical trial is to evaluate whether primary total pancreatectomy with simultaneous islet autotransplantation compared with pancreatic head resection (alone) can reduce perioperative morbidity and time to initiation of adjuvant therapy in patients with a high-risk constellation for pancreatic fistulas.
Trial Details
NCT Number NCT05843877
Lead Sponsor Technische Universität Dresden
Collaborators: German Cancer Research Center
Conditions
(from sponsor)		 Periampullary Cancer, Postoperative Pancreatic Fistula
Enrollment 32 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov